Article
The FVB-nmd SMARD1 mouse presents with early respiratory deficits and pathology that significantly impact lifespan.
Human molecular genetics - 26 Jun 2026
Muchow Roxanne, Woolridge Michelle, Smith Catherine L, Llorente Torres Francisco J, Perez-Lopez Dennis, Nichols Nicole L, Lorson Christian L, Lorson Monique A
Abstract excerpt
Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is a rare, inherited genetic disease caused by mutations in the immunoglobulin mu binding protein (IGHMBP2) gene that result in spinal muscular atrophy with respiratory distress (SMARD1) or Charcot-Marie-Tooth Type 2S (CMT2S). SMARD1 clinical symptoms include respiratory failure, progressive muscular weakness, feeding deficiencies, and sensory and...
Topics
Join the communities discussing this publication.
